These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 35810621)

  • 1. Disparities in opioid overdose survival and naloxone administration in Pennsylvania.
    Holmes LM; Rishworth A; King BH
    Drug Alcohol Depend; 2022 Sep; 238():109555. PubMed ID: 35810621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
    Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
    J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A descriptive study of racial and ethnic differences of drug overdoses and naloxone administration in Pennsylvania.
    Barboza GE; Angulski K
    Int J Drug Policy; 2020 Apr; 78():102718. PubMed ID: 32199352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
    Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
    Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
    Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
    J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy Naloxone Standing Order and Community Opioid Fatality Rates Over Time.
    Xuan Z; Walley AY; Yan S; Chatterjee A; Green TG; Pollini RA
    JAMA Netw Open; 2024 Aug; 7(8):e2427236. PubMed ID: 39207758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone for Opioid Overdose: Comment.
    Milas BL; Varon AJ
    Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
    [No Abstract]   [Full Text] [Related]  

  • 8. Naloxone for Opioid Overdose: Comment.
    Pattullo GG
    Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal Naloxone for Opioid Overdose.
    Taylor JL; Lasser KE
    JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
    Alexander M; Hooker J; Stratton M; Huh M; Houck K
    J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality.
    Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC
    Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone administration among opioid-involved overdose deaths in 38 United States jurisdictions in the State Unintentional Drug Overdose Reporting System, 2019.
    Quinn K; Kumar S; Hunter CT; O'Donnell J; Davis NL
    Drug Alcohol Depend; 2022 Jun; 235():109467. PubMed ID: 35461083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pennsylvania's Community Coordination Strategy to Reduce Opioid Overdose Deaths.
    Cloutier RM; Aldridge A; Hoffman G; Boyd KL; Wang EH; Foster K; Snyder K; Dowd W; Pringle JL
    J Stud Alcohol Drugs; 2023 Jul; 84(4):605-614. PubMed ID: 36971737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
    Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
    Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of untargeted naloxone distribution on opioid overdose outcomes.
    Dowd WN
    Health Econ; 2023 Dec; 32(12):2801-2818. PubMed ID: 37670413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
    Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
    Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reprint of: Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
    Alexander M; Hooker J; Stratton M; Huh M; Houck K
    J Am Pharm Assoc (2003); 2024; 64(4S):102168. PubMed ID: 39127946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where Opioid Overdose Patients Live Far From Treatment: Geospatial Analysis of Underserved Populations in New York State.
    Abell-Hart K; Rashidian S; Teng D; Rosenthal RN; Wang F
    JMIR Public Health Surveill; 2022 Apr; 8(4):e32133. PubMed ID: 35412467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.